Nephron Clinical Practice
Original Paper
Estimating the Glomerular Filtration Rate in the General Population Using Different Equations: Effects on Classification and AssociationPattaro C.a · Riegler P.c · Stifter G.d · Modenese M.a · Minelli C.a · Pramstaller P.P.a,b,eaCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC), and bDepartment of Neurology, Hospital of Bolzano, Bolzano, cHemodialysis Unit, Hospital of Merano, Merano, and dDivision of Internal Medicine, Hospital of Brunico, Brunico, Italy; eDepartment of Neurology, University of Lübeck, Lübeck, Germany
|
|
Log in to MyKarger to check if you already have access to this title.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Subscribe
For eJournal Archive and eJournal Backfiles information please contact Karger service
Article / Publication Details
Received: July 23, 2012
Accepted: April 03, 2013
Published online: June 22, 2013
Issue release date: August 2013
Number of Print Pages: 10
Number of Figures: 4
Number of Tables: 5
eISSN: 1660-2110 (Online)
For additional information: https://www.karger.com/NEC
Abstract
Background/Aims: Several formulas for glomerular filtration rate (GFR) estimation, based on serum creatinine or cystatin C, have been proposed. We assessed the impact of some of these equations on estimated GFR (eGFR) and chronic kidney disease (CKD) prevalence, and on the association with cardiovascular risk factors, in a general population sample characterized by a young mean age. Methods: We studied 1,199 individuals from three Alpine villages enrolled into the MICROS study. eGFR was obtained with the 4- and 6-parameter MDRD study equations, the Virga equation, and with the three CKD-EPI formulas for creatinine, cystatin C, and the combination of creatinine and cystatin C. We assessed the concordance between quantitative eGFR levels, CKD prevalence, and in terms of association with total, LDL, and HDL cholesterol. Results: The highest and lowest eGFR levels corresponded to the cystatin C-based and MDRD-4 equations, respectively. CKD prevalence varied from 1.8% (Virga) to 5.8% (MDRD-4). The CKD-EPI based on creatinine showed the highest agreement with all other equations. Agreement between methods was higher at lower eGFR levels, older age, and in the presence of diabetes and hypertension. Creatinine-based estimates of eGFR were associated with total and low-density lipoprotein but not high-density lipoprotein cholesterol. The opposite was observed for the cystatin C-based GFR. Conclusion: GFR estimation is strongly affected by the chosen equation. Differences are more pronounced in healthy and younger individuals. To identify CKD risk factors, the choice of the equation is of secondary importance to the choice of the biomarker used in the formula. If eGFR is not calibrated to a gold standard GFR in the general population, reports about CKD prevalence should be considered with caution.
© 2013 S. Karger AG, Basel
References
- Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047.
- Zhang QL, Rothenbacher D: Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008;8:117.
- Marroni F, Grazio D, Pattaro C, Devoto M, Pramstaller P: Estimates of genetic and environmental contribution to 43 quantitative traits support sharing of a homogeneous environment in an isolated population from South Tyrol, Italy. Hum Hered 2008;65:175-182.
- Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
- Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20-29.
- Virga G, Gaspari F, Thomaseth K, Cara M, Mastrosimone S, Rossi V: A new equation for estimating renal function using age, body weight and serum creatinine. Nephron Clin Pract 2007;105:c43-c53.
- Pattaro C, Marroni F, Riegler A, Mascalzoni D, Pichler I, Volpato CB, Dal Cero U, De Grandi A, Egger C, Eisendle A, Fuchsberger C, Gogele M, Pedrotti S, Pinggera GK, Stefanov SA, Vogl FD, Wiedermann CJ, Meitinger T, Pramstaller PP: The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives. BMC Med Genet 2007;8:29.
- Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology Collaboration: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-254.
- Lin LI: A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-268.
- Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-310.
-
Fleiss JL, Levin B, Paik MC: Statistical Methods for Rates and Proportions, London, Wiley, 2003.
- Welch BL: The generalisation of student's problems when several different population variances are involved. Biometrika 1947;34:28-35.
- Aulchenko YS, Ripke S, Isaacs A, van Duijn CM: GenABEL: an R library for genome-wide association analysis. Bioinformatics 2007;23:1294-1296.
- Pattaro C, De Grandi A, Vitart V, et al: A meta-analysis of genome-wide data from five European isolates reveals an association of COL22A1, SYT1, and GABRR2 with serum creatinine level. BMC Med Genet 2010;11:41.
- Kottgen A, Pattaro C, Boger CA, et al: New loci associated with kidney function and chronic kidney disease. Nat Genet 2010;42:376-384.
- Pattaro C, Kottgen A, Teumer A, et al: Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 2012;8:e1002584.
- Gifford FJ, Methven S, Boag DE, Spalding EM, Macgregor MS: Chronic kidney disease prevalence and secular trends in a UK population: the impact of MDRD and CKD-EPI formulae. Q J Med 2011;104:1045-1053.
- Murata K, Baumann NA, Saenger AK, Larson TS, Rule AD, Lieske JC: Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol 2011;6:1963-1972.
- Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS, Chronic Kidney Disease Prognosis Consortium: Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-1951.
- Carter JL, Stevens PE, Irving JE, Lamb EJ: Estimating glomerular filtration rate: comparison of the CKD-EPI and MDRD equations in a large UK cohort with particular emphasis on the effect of age. QJM 2011;104:839-847.
- Giavarina D, Cruz DN, Soffiati G, Ronco C: Comparison of estimated glomerular filtration rate (eGFR) using the MDRD and CKD-EPI equations for CKD screening in a large population. Clin Nephrol 2010;74:358-363.
- Delanaye P, Cavalier E, Mariat C, Maillard N, Krzesinski JM: MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrol 2010;11:8.
-
O'Callaghan CA, Shine B, Lasserson DS: Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open 2011;1:e000308.
External Resources
- Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, Steffes MW, Eggers PW, Coresh J, Levey AS: Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 ml/min/1.73 m2. Am J Kidney Dis 2010;56:486-495.
- Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
- Emara M, Zahran A, Abd El Hady H, Shoker A: How to best define patients with moderate chronic kidney disease. Nephron Clin Pract 2008;110:c195-c206.
- Zahran A, Hossain MA, Kora MA, Galal AZ, Shoker A: Validation of the Virga GFR equation in a renal transplant population. Nephron Clin Pract 2008;109:c140-c147.
- Estrella MM, Astor BC, Kottgen A, Selvin E, Coresh J, Parekh RS: Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94). Nephrol Dial Transplant 2010;25:2542-2548.
- Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT: Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 2010;5:1003-1009.
- de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H: Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. Nephron Clin Pract 2011;117:c213-c224.
- Zhang QL, Koenig W, Raum E, Stegmaier C, Brenner H, Rothenbacher D: Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009;48:122-127.
- de Boer IH, Astor BC, Kramer H, Palmas W, Seliger SL, Shlipak MG, Siscovick DS, Tsai MY, Kestenbaum B: Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 2008;3:125-132.
- Morita Y, Homma Y, Igarashi M, Miyano R, Yamaguchi H, Matsuda M, Tanigaki T, Shiina Y, Homma K: Decrease in glomerular filtration rate by plasma low-density lipoprotein cholesterol in subjects with normal kidney function assessed by urinalysis and plasma creatinine. Atherosclerosis 2010;210:602-606.
- Ford I, Bezlyak V, Stott DJ, Sattar N, Packard CJ, Perry I, Buckley BM, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J: Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Med 2009;6:e16.
- Oda E, Kawai R: Low-density lipoprotein (LDL) cholesterol is cross-sectionally associated with preclinical chronic kidney disease (CKD) in Japanese men. Intern Med 2010;49:713-719.
- Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, Ferrieres J, Juhan-Vague I, Fruchart JC, Ducimetiere P, PRIME Study Group: Plasma cystatin-C and development of coronary heart disease: the PRIME Study. Atherosclerosis 2006;185:375-380.
- Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de Zeeuw D, de Jong PE, PREVEND Study Group: The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005;67:1967-1973.
- Krikken JA, Gansevoort RT, Dullaart RP, PREVEND Study Group: Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. J Lipid Res 2010;51:1982-1990.
- Retnakaran R, Connelly PW, Harris SB, Zinman B, Hanley AJ: Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth. Pediatr Nephrol 2007;22:1007-1013.
Article / Publication Details
Received: July 23, 2012
Accepted: April 03, 2013
Published online: June 22, 2013
Issue release date: August 2013
Number of Print Pages: 10
Number of Figures: 4
Number of Tables: 5
eISSN: 1660-2110 (Online)
For additional information: https://www.karger.com/NEC
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission